Foot Locker, Inc. financial data

Symbol
FL on NYSE
Location
Foot Locker, Inc., 330 West 34 Th Street, New York, NY
Fiscal year end
February 1
Latest financial report
10-Q - Q2 2025 - Sep 2, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 165 % -1.28%
Quick Ratio 117 % -2.71%
Return On Equity -14.1 % -14.3%
Return On Assets -5.77 % -11.4%
Operating Margin -2.58 % -336%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 95.6M shares +0.76%
Entity Public Float 1.32B USD +2.78%
Weighted Average Number of Shares Outstanding, Basic 95.6M shares +0.63%
Weighted Average Number of Shares Outstanding, Diluted 95.6M shares +0.63%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 7.86B USD -3.58%
Operating Income (Loss) -203M USD -328%
Nonoperating Income (Expense) -36M USD +93.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -248M USD +48.1%
Income Tax Expense (Benefit) 131M USD
Net Income (Loss) Attributable to Parent -385M USD -5.48%
Earnings Per Share, Basic -4 USD/shares -3.6%
Earnings Per Share, Diluted -4 USD/shares -3.87%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 299M USD +2.75%
Inventory, Net 1.71B USD +3.7%
Other Assets, Current 364M USD -9.9%
Assets, Current 2.37B USD +1.24%
Deferred Income Tax Assets, Net 41M USD -68.5%
Property, Plant and Equipment, Net 899M USD -0.66%
Operating Lease, Right-of-Use Asset 2.05B USD -5.57%
Intangible Assets, Net (Excluding Goodwill) 227M USD -42.2%
Goodwill 655M USD -14.3%
Other Assets, Noncurrent 146M USD +53.7%
Assets 6.51B USD -6.41%
Accounts Payable, Current 542M USD +11.3%
Employee-related Liabilities, Current 65M USD -9.72%
Liabilities, Current 1.49B USD +5.45%
Long-term Debt and Lease Obligation 440M USD 0%
Deferred Income Tax Liabilities, Net 149M USD +6.43%
Operating Lease, Liability, Noncurrent 1.84B USD -6.83%
Other Liabilities, Noncurrent 157M USD -30.5%
Liabilities 3.93B USD -3.13%
Common Stocks, Including Additional Paid in Capital 817M USD +2.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -327M USD +11.6%
Retained Earnings (Accumulated Deficit) 2.09B USD -15.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 2.58B USD -11%
Liabilities and Equity 6.51B USD -6.41%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3M USD -105%
Net Cash Provided by (Used in) Financing Activities -4M USD -300%
Net Cash Provided by (Used in) Investing Activities -52M USD +31.6%
Common Stock, Shares, Issued 95.7M shares +0.71%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -55M USD -224%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 328M USD +1.86%
Interest Paid, Excluding Capitalized Interest, Operating Activities 9M USD +12.5%
Deferred Tax Assets, Valuation Allowance 112M USD +17.9%
Deferred Tax Assets, Gross 927M USD -0.11%
Operating Lease, Liability 2.34B USD -6.33%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -342M USD -1.18%
Lessee, Operating Lease, Liability, to be Paid 2.99B USD -8.88%
Property, Plant and Equipment, Gross 1.28B USD -12.4%
Operating Lease, Liability, Current 482M USD -2.82%
Lessee, Operating Lease, Liability, to be Paid, Year Two 501M USD -4.21%
Lessee, Operating Lease, Liability, to be Paid, Year One 624M USD +4.35%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) 69M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 443M USD -9.41%
Lessee, Operating Lease, Liability, to be Paid, Year Three 396M USD -8.12%
Unrecognized Tax Benefits 39M USD -22%
Lessee, Operating Lease, Liability, to be Paid, Year Four 320M USD -8.83%
Operating Lease, Payments 177M USD +2.91%
Deferred Tax Assets, Net of Valuation Allowance 815M USD -2.16%
Share-based Payment Arrangement, Expense 21M USD -4.55%